Contribute Try STAT+ Today

09oct8:15 amFeaturedCRISPR: From lab to clinicThe Broad Institute Hosted by: STAT

Hosted by


Event Details

Advances in use of the CRISPR genome editing technology have been arriving at breakneck speed. But even as the first clinical trials of the technique are expected to start before the end of the year, scientists have found that CRISPR might in some circumstances pose unexpected risks to patients.

During HUBweek, STAT’s Sharon Begley — along with a panel of experts — will explore the newest forms and uses of CRISPR, its potential to cure now-incurable diseases, and the challenges of turning a revolutionary lab technique into a therapy. Coffee and snacks will be provided. Register below to reserve a seat.

Sharon Begley, Senior Writer, Science and Discovery, STAT

Erik Sontheimer, Ph.D., Professor at UMass Medical School, CoFounder of Intellia Therapeutics, Inc.
Nicole Gaudelli, Ph.D., Senior Scientist, Program Leader, Beam Therapeutics
Vikram Pattanayak, M.D., Ph.D., Assistant in Pathology at Massachusetts General Hospital

Sponsor Welcome
Kevin Holden, Head of Synthetic Biology, Synthego

Sponsor Perspective
Paul Dabrowski, CEO, Synthego

Underwritten by



Oct. 9, 8:15-9:30 a.m.


The Broad Institute

415 Main St.

Cambridge, MA